HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway.

Abstract
Acute lung injury (ALI) from a variety of clinical disorders, characterized by diffuse inflammation, is a cause of acute respiratory failure that develops in patients of all ages. Previous studies reported that wogonin, a flavonoid-like chemical compound which was found in Scutellaria baicalensis, has anti-inflammatory effects in several inflammation models, but not in ALI. Here, the in vivo protective effect of wogonin in the amelioration of lipopolysaccharide (LPS) -induced lung injury and inflammation was assessed. In addition, the in vitro effects and mechanisms of wogonin were studied in the mouse macrophage cell lines Ana-1 and RAW264.7. In vivo results indicated that wogonin attenuated LPS-induced histological alterations. Peripheral blood leucocytes decreased in the LPS-induced group, which was ameliorated by wogonin. In addition, wogonin inhibited the production of several inflammatory cytokines, including tumour necrosis factor-α, interleukin-1β (IL-1β) and IL-6, in the bronchoalveolar lavage fluid and lung tissues after LPS challenge, while the peroxisome proliferator-activated receptor γ (PPARγ) inhibitor GW9662 reversed these effects. In vitro results indicated that wogonin significantly decreased the secretion of IL-6, IL-1β and tumour necrosis factor-α in Ana-1 and RAW264.7 cells, which was suppressed by transfection of PPARγ small interfering RNA and GW9662 treatment. Moreover, wogonin activated PPARγ, induced PPARγ-mediated attenuation of the nuclear translocation and the DNA-binding activity of nuclear factor-κB in vivo and in vitro. In conclusion, all of these results showed that wogonin may serve as a promising agent for the attenuation of ALI-associated inflammation and pathology by regulating the PPARγ-involved nuclear factor-κB pathway.
AuthorsJing Yao, Di Pan, Yue Zhao, Li Zhao, Jie Sun, Yu Wang, Qi-Dong You, Tao Xi, Qing-Long Guo, Na Lu
JournalImmunology (Immunology) Vol. 143 Issue 2 Pg. 241-57 (Oct 2014) ISSN: 1365-2567 [Electronic] England
PMID24766487 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 John Wiley & Sons Ltd.
Chemical References
  • Anti-Inflammatory Agents
  • Cytokines
  • Flavanones
  • Inflammation Mediators
  • Lipopolysaccharides
  • NF-kappa B
  • PPAR gamma
  • lipopolysaccharide, E coli O55-B5
  • wogonin
Topics
  • Acute Lung Injury (chemically induced, genetics, immunology, metabolism, prevention & control)
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Cell Line
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Female
  • Flavanones (pharmacology)
  • Gene Expression Regulation
  • Inflammation Mediators (metabolism)
  • Lipopolysaccharides
  • Lung (drug effects, immunology, metabolism)
  • Macrophages (drug effects, immunology, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • NF-kappa B (metabolism)
  • PPAR gamma (drug effects, genetics, metabolism)
  • Pneumonia (chemically induced, genetics, immunology, metabolism, prevention & control)
  • RNA Interference
  • Signal Transduction (drug effects)
  • Time Factors
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: